Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 Sturmer Michael E PRESIDENT Sale 10b5-1 −4,515 $31.95 $144K 380,038
2024-04-01 Anevski Peter CHIEF EXECUTIVE OFFICER Shares withheld for taxes −7,977 $38.15 $304K 247,917
2024-04-01 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +1,000 $3.95 $4K 87,312
2024-04-01 Schlanger David J Executive Chairman Shares withheld for taxes 10b5-1 −2,681 $38.15 $102K 84,631
2024-04-01 Schlanger David J Executive Chairman Sale 10b5-1 −1,000 $37.52 $38K 83,631
2024-04-01 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −1,000 1,309,022
2024-04-01 Sturmer Michael E PRESIDENT Sale 10b5-1 −4,515 $37.60 $170K 386,433
2024-04-01 Sturmer Michael E PRESIDENT Sale 10b5-1 −1,880 $37.60 $71K 384,553
2024-04-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +20,627 $3.95 $81K 72,875
2024-04-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes 10b5-1 −11,591 $37.64 $436K 61,284
2024-04-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −2,129 $37.60 $80K 59,155
2024-04-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −9,036 $37.62 $340K 50,119
2024-04-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −20,627 0
2024-03-27 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +71,272 $3.95 $282K 157,584
2024-03-27 Schlanger David J Executive Chairman Sale 10b5-1 −71,272 $37.80 $2.7M 86,312
2024-03-27 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −71,272 1,310,022
2024-03-26 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +305 $3.95 $1K 86,617
2024-03-26 Schlanger David J Executive Chairman Sale 10b5-1 −305 $37.50 $11K 86,312
2024-03-26 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −305 1,381,294
2024-03-25 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +2,597 $3.95 $10K 88,909

Page 13 of 77 · 1,524 trades